MedTrace Logo

The EXPLORE MG Registry for Myasthenia Gravis

NCT03792659 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-11-28

No results posted yet for this study

Summary

The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.

Conditions

Interventions

OTHER

Blood Sample Draw

Approximately 100 cc (less than 1/2 cup) of blood will be drawn from both groups.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Richard Nowak, MD, MS · Assistant Professor, Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-30
Primary Completion
2026-09-30
Completion
2026-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03792659 on ClinicalTrials.gov